Thomas Grosse-Puppendahl
Vice President, Operations @ Evonik Venture Capital
Essen, Germany
Thomas Grosse-Puppendahl is a Vice President at Evonik.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Thomas Grosse-Puppendahl invests in
Stages Thomas Grosse-Puppendahl invests in
Countries Thomas Grosse-Puppendahl invests in
Investment Focus
Industry
- 3D Printing 2 (67%)
- Medical 1 (33%)
- Software 1 (33%)
- Health Care 1 (33%)
- Manufacturing 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
Country
- China 1 (33%)
- Israel 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Castor Technologies LTD
|
CASTOR’s proprietary technology helps manufacturers assess how to apply advanced manufacturing to their production processes. By providing a comprehensive technical and cost-savings assessment for a full bill of materials, designers, NPI managers and production engineers have the critical information they need to effectively and efficiently makemachine parts. | $3.5M / Seed / Aug 16, 2021 | |
|
Castor Technologies LTD
|
CASTOR’s proprietary technology helps manufacturers assess how to apply advanced manufacturing to their production processes. By providing a comprehensive technical and cost-savings assessment for a full bill of materials, designers, NPI managers and production engineers have the critical information they need to effectively and efficiently makemachine parts. | $2M / Seed / Oct 24, 2019 | |
Medvance
|
Medvance is one of the pioneers in the development of 3D printed PEEK medical implants. Evonik has always been our trusted raw material partner. This investment will further promote The company's development has helped us bring innovative solutions to patients and doctors in China and then to the world." | Series A / Sep 06, 2019 |
Co-Investors
TAU Ventures
2 deals together
Puhua Capital
1 deal together
Spring Ventures
1 deal together
The Chartered Group
1 deal together
Xerox
1 deal together
About Evonik Venture Capital
Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, one of the providers of specialty chemicals. Evonik Venture Capital invests in young companies with innovative technology and high growth potential with solutions to problems within the areas of focus of resource efficiency, specialty additives, health & care,nutrition.
Evonik Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bernhard Mohr
Managing Director
|
|||
Eric Breese
Investment Director
|
|||
Lars Bönisch
Venture Capitalist
|
|||
Lutz Stoeber
Investment Director
|
|||
|
Thomas Grosse-Puppendahl
Vice President, Operations
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Thomas Grosse-Puppendahl invest in?
Thomas Grosse-Puppendahl invests primarily in 3D Printing, Medical and Software startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Thomas Grosse-Puppendahl last invest?
The most recent investment recorded for Thomas Grosse-Puppendahl closed in Aug 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
